Huntington National Bank
RPRX icon

Huntington National Bank’s Royalty Pharma RPRX Stock Holding History

Huntington National Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Buy
55,717
+54,961
+7,270% +$2.86M 0.02% 342
2026
Q1 		$36.3K Hold
756
– – ﹤0.01% 1450
2025
Q4 		$29.2K Hold
756
– – ﹤0.01% 1446
2025
Q3 		$26.7K Hold
756
– – ﹤0.01% 1498
2025
Q2 		$27.2K Buy
756
+144
+24% +$4.77K ﹤0.01% 1464
2025
Q1 		$19.1K Buy
612
+72
+13% +$2.28K ﹤0.01% 1535
2024
Q4 		$13.8K Buy
540
+378
+233% +$10K ﹤0.01% 1654
2024
Q3 		$4.58K Buy
162
+10
+7% +$277 ﹤0.01% 2022
2024
Q2 		$4.01K Sell
152
-96
-39% -$2.66K ﹤0.01% 1969
2024
Q1 		$7.53K Buy
248
+73
+42% +$2.15K ﹤0.01% 1782
2023
Q4 		$4.92K Sell
175
-86
-33% -$2.36K ﹤0.01% 1897
2023
Q3 		$7.08K Sell
261
-142
-35% -$4.22K ﹤0.01% 1690
2023
Q2 		$12.4K Sell
403
-33
-8% -$1.12K ﹤0.01% 1504
2023
Q1 		$15.7K Buy
436
+175
+67% +$6.49K ﹤0.01% 1411
2022
Q4 		$10.3K Sell
261
-120
-31% -$5.01K ﹤0.01% 1482
2022
Q3 		$15K Sell
381
-644
-63% -$27.5K ﹤0.01% 1406
2022
Q2 		$43K Hold
1,025
– – ﹤0.01% 1051
2022
Q1 		$40K Hold
1,025
– – ﹤0.01% 1134
2021
Q4 		$41K Buy
+1,025
New +$39.8K ﹤0.01% 1139

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Huntington National Bank's RPRX Position: Q2 2026 in Review

Huntington National Bank increased its Royalty Pharma (RPRX) stake by 7,270% in Q2 2026, buying an estimated $2.86M and bringing the position to 55,717 shares worth $3.12M. The position accounts for 0.02% of the portfolio, ranked #342.

Huntington National Bank first reported a position in RPRX in Q4 2021 and has held it in 19 quarters since. 648 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Huntington National Bank held 55,717 shares of Royalty Pharma worth $3.12M as of Q2 2026.
  • Huntington National Bank bought 54,961 Royalty Pharma shares in Q2 2026, an estimated $2.86M.
  • Royalty Pharma made up 0.02% of Huntington National Bank's portfolio in Q2 2026, its #342 holding.
  • Huntington National Bank first reported a position in Royalty Pharma in Q4 2021 and has held it in 19 quarters since.
  • 648 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.